Current treatment options for female urinary incontinence - A review

International Journal of Fertility and Women's Medicine

Volumn 49, Issue 3, 2004, Pages 102-112

  Davila, G Willy ^a   Guerette, Nathan ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

Behavior modification; Biofeedback; Detrusor instability; Functional electrical stimulation; Mixed incontinence; New treatments; Pharmacologic therapy; Slings; Stress urinary incontinence; Surgical therapy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CONJUGATED ESTROGEN; DESMOPRESSIN; DULOXETINE; EPHEDRINE; ESTROGEN; GESTAGEN; HYOSCYAMINE; IMIPRAMINE; LEVSINEX; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PHENYLPROPANOLAMINE; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

BEHAVIOR MODIFICATION; BLADDER FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COLPOSUSPENSION; DETRUSOR DYSSYNERGIA; DEVICE; DIET; DISEASE SEVERITY; ELECTROSTIMULATION; EXERCISE; FEEDBACK SYSTEM; FEMALE; FLUID INTAKE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; META ANALYSIS; MICTURITION; MIXED INCONTINENCE; NEUROMUSCULAR FUNCTION; NONHUMAN; ONSET AGE; PHYSIOTHERAPY; PRIORITY JOURNAL; PULSE GENERATOR; QUALITY OF LIFE; RADIOFREQUENCY; REVIEW; SIDE EFFECT; STRESS INCONTINENCE; STROKE; SUBURETHRAL SLING; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; URETHRA FUNCTION; URETHRAL CAP; URETHRAL INSERT; URETHRAL PLUG; URGE INCONTINENCE; URINE INCONTINENCE; VAGINA PESSARY; XEROSTOMIA;

ADULT; AGE FACTORS; AGED; BIOFEEDBACK (PSYCHOLOGY); ELECTRIC STIMULATION THERAPY; EXERCISE THERAPY; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; QUALITY OF LIFE; RISK FACTORS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; URINARY INCONTINENCE; URINARY INCONTINENCE, STRESS; WOMEN'S HEALTH;

EID: 3543006545     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Luber KM, Boero S, Choe JY: The demographics of pelvic floor disorders: Current observations and future projections. Am J Obstet Gynecol 184:1496-1503, 2001.
2. Davila GW: Urinary incontinence in women: How to help patients regain bladder control. Postgrad Med 96:103-110, 1994.
3. Diokno A: The benefits of conservative management for SUI. Contemporary OB/GYN 128, 131, 135-136, 138, 141-142, March 1997.
4. Karram MM, Bhatia NN: Management of coexistent stress and urge urinary incontinence. Obstet Gynecol 73:4-7, 1989.
5. Hullfish KL, Bovbjerg VE, Steers GJ: Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved? Am J Obstet Gynecol 187:88-92, 2002.
6. Valtin H: "Drink at least eight glasses of water a day." Really? Is there scientific evidence for "8 × 8"? Am J Physiol Regul Integr Comp Physiol 283:R993-R1004, 2002.
7. Bryant CM, Dowell CJ, Fairbrother G: Caffeine reduction education to improve urinary symptoms. Br J Nurs 11:560-565, 2002.
8. Arya LA, Myers DL, Jackson ND: Dietary caffeine intake and the risk for detrusor instability: A case-control study. Obstet Gynecol 96:85-89, 2000.
9. Baggish MS, Sze EH, Johnson R: Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol 177:507-511, 1997.
10. Burgio KL, Whitehead WE, Engel BT: Urinary incontinence in the elderly. Bladder-sphincter biofeedback and toileting skills training. Ann Intern Med 103:507-515, 1985.
11. Bump RC, Sugerman HJ, Fantl JA, et al: Obesity and lower urinary tract function in women: Effect of surgically induced weight loss. Am J Obstet Gynecol 167:392-397, 1992.
12. Subak LL, Johnson C, Whitcomb E, et al: Does weight loss improve incontinence in moderately obese women? Int Urogynecol J 13:40-43, 2002.
13. Fantl JA, Wyman JF, McClish DK, et al: Efficacy of bladder training in older women with urinary incontinence. JAMA 265:609-613, 1991.
14. Kegel AH: Physiologic therapy for urinary incontinence. JAMA 146:915-917, 1951.
15. Ferguson KL, McKey PL, Bishop KR, et al: Stress urinary incontinence: Effect of pelvic muscle exercise. Obstet Gynecol 75:671-675, 1990.
16. Mouritsen L, Frimodt-Moller C, Moller M: Long-term effect of pelvic floor exercises on female urinary incontinence. Br J Urol 68:32-37, 1991.
17. Olah KS, Bridges N, Denning J, et al: The conservative management of patients with symptoms of stress incontinence: A randomized, prospective study comparing weighted vaginal cones and interferential therapy. Am J Obstet Gynecol 162:87-92, 1990.
18. Martan A, Halaska M, Voigt R, et al: Ultrasound of the bladder neck-urethra transition before and after pelvic floor training with Kolpexin [German]. Zentralbl Gynäkol 116:416-418, 1994.
19. Elia G, Bergman A: Pelvic muscle exercises: When do they work? Obstet Gynecol 81:283-286, 1993.
20. Burgio KL, Robinson JC, Engel BT: The role of biofeedback in Kegel exercise training for stress urinary incontinence. Am J Obstet Gynecol 154:58-64, 1986.
21. Cardozo LD, Abrams PD, Stanton SL, et al: Idiopathic bladder instability treated by biofeedback. Br J Urol 50:521-523, 1978.
22. Devreeze AM, Vereecken RL, Van Assche FA: Perineal physiotherapy in the treatment of female urinary incontinence as an alternative to surgery. Int Urogynecol J 3:33-37, 1992.
23. Morkved S, Bo K, Fjortoft T: Effect of adding biofeedback to pelvic floor muscle training to treat urodynamic stress incontinence. Obstet Gynecol 100:730-739, 2002.
24. Davila GW, Bernier F: Multimodality pelvic physiotherapy treatment of urinary incontinence in adult women. Int Urogynecol J 6:187-194, 1995.
25. Brubaker L, Benson JT, Bent A, et al: Transvaginal electrical stimulation for female urinary incontinence. Am J Obstet Gynecol 177:536-540, 1997.
26. Bent AE, Sand PK, Ostergard DR, et al: Transvaginal electrical stimulation in the treatment of genuine stress incontinence and detrusor instability. Int Urogynecol J 4:9-13, 1993.
27. Erikson BC, Mjolnerod OK: Changes in urodynamic measurements after successful anal electrostimulation in female urinary incontinence. Br J Urol 59:45-49, 1987.
28. Sand PK, Richardson DA, Staskin DR, et al: Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: A multicenter, placebo-controlled trial. Am J Obstet Gynecol 173:72-79, 1995.
29. Bhatia NN, Bergman A, Gunning JE: Urodynamic effects of a vaginal pessary in women with stress urinary incontinence. Am J Obstet Gynecol 147:876-884, 1983.
30. Moore KH, Simons A, Dowell C, et al: Efficacy and user acceptability of the urethral occlusive device in women with urinary incontinence. J Urol 162:464-468, 1999.
31. Sirls LT, Foote JE, Kaufman JM, et al: Long-term results of the FemSoft urethral insert for the management of female stress urinary incontinence. Int Urogynecol J 13:88-95, 2002.
32. Fantl JA, Bump RC, Robinson D, et al: Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group. Obstet Gynecol 88:745-749, 1996.
33. Walter S, Kjaergaard B, Lose G, et al: Stress urinary incontinence in postmenopausal women treated with oral estrogen (estriol) and an alpha adrenoceptor stimulating agent (phenylpropanolaminel. A randomized double-blind placebo-controlled study. Int Urogynecol J 1:74-79, 1990.
34. Grady D, Brown JS, Vittinghoff E, et al: Postmenopausal hormones and incontinence: The Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 97:116-120, 2001.
35. Gilja I, Radej M, Kovaci M, et al: Conservative treatment of female stress incontinence with imipramine. J Urol 132:909-911, 1984.
36. Sullivan J, Abrams P: Pharmacological management of incontinence. Eur Urol 36(suppl 1):89-95, 1999.
37. Kernan WN, Viscoli CM, Brass LM, et al: Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 343:1826-1832, 2000.
38. Norton PA, Zinner NR, Yalcin I, et al: Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 187:40-48, 2002.
39. Gleason DM, Susset J, White C, et al: Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group. Urology 54:420-423, 1999.
40. Anderson RU, Mobley D, Blank B, et al: Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group. J Urol 161:1809-1812, 1999.
41. Birns J, Lukkari E, Malone-Lee JG: A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once dailyl with conventional oxybutynin tablets (5 mg twice dailyl in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin. BJU Int 85:793-798, 2000.
42. Versi E, Appell R, Mobley D, et al: Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group. Obstet Gynecol 95:718-721, 2000.
43. Davila GW, Daugherty CA, Sanders SW, et al: A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence. J Urol 166:140-145, 2001.
44. Dmochowski RR, Davila GW, Zinner NR, et al: Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. J Urol 168:580-586, 2002.
45. Van Kerrebroeck P, Kreder K, Jonas U, et al: Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology 57:414-421, 2001.
46. Appell RA, Sand P, Dmochowski R, et al: Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. Mayo Clin Proc 76:358-363, 2001.
47. Sussman D, Garely A: Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: The Antimuscarinic Clinical Effectiveness Trial (ACET). Curr Med Res Opin 18:177-184, 2002.
48. Mattiasson A, Abrams P, Van Kerrebroeck P, et al: Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 89:855-862, 2002.
49. Sand PK, Bowen LW, Panganiban R, et al: The low pressure urethra as a factor in failed retropubic urethropexy. Obstet Gynecol 69:399-402, 1987.
50. Burch JC: Urethrovaginal fixation to Cooper's ligament for correction of stress incontinence, cystocele and prolapse. Am J Obstet Gynecol 81:281-286, 1961.
51. Tanagho EA: Colpocystourethropexy: the way we do it. J Urol 116:751-753, 1978.
52. Bergman A, Elia G: Three surgical procedures for genuine stress incontinence: five-year follow-up of a prospective randomized study. Am J Obstet Gynecol 173:66-71, 1995.
53. Alcalay M, Monga A, Stanton SL: Burch colposuspension: a 10-20 year follow-up. Br J Obstet Gynaecol 102:740-745, 1995.
54. Vierhout ME, Mulder AF: De novo detrusor instability after Burch colposuspension. Acta Obstet Gynecol Scand 71:414-416, 1992.
55. Galloway NT, Davies N, Stephenson TP: The complications of colposuspension. Br J Urol 60:122-124, 1987.
56. Colombo M, Milani R, Vitobello D, et al: A randomized comparison of Burch colposuspension and abdominal paravaginal defect repair for female stress urinary incontinence. Am J Obstet Gynecol 175:78-84, 1996.
57. Kammerer-Doak DN, Cornella JL, Magrina JF, et al: Osteitis pubis after Marshall-Marchetti-Krantz urethropexy: a pubic osteomyelitis. Am J Obstet Gynecol 179:586-590, 1998.
58. Nieves A: Long-term results of laparoscopic Burch. J Am Assoc Gynecol Laparosc 3(4, Suppl):S35, 1996.
59. Lobel RW, Davis GD: Long-term results of laparoscopic Burch urethropexy. J Am Assoc Gynecol Laparosc 4:341-345, 1997.
60. Ross JW: Laparoscopic Burch repair compared with laparotomy Burch to cure urinary stress incontinence. J Am Assoc Gynecol Laparosc 2:47-48, 1995.
61. Nilsson CG, Kuuva N, Falconer C, et al: Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence. Int Urogynecol J 12(Suppl 2):S5-S8, 2001.
62. Kohli N, Karram MM: Surgery for genuine stress incontinence: Vaginal procedures, injections, and the artificial urinary sphincter, in Walters MD, Karram MM (eds): Urogynecology and Reconstructive Pelvic Surgery. St. Louis, Mosby, pp 171-196, 1999.
63. Appell RA: New developments: Injectables for urethral incontinence in women. Int Urogynecol J 1:117-119, 1990.
64. McGuire EJ, Appell RA: Transurethral collagen injection for urinary incontinence. Urology 43:413-415, 1994.
65. Glowacki CA, Nguyen JK, Bhatia NN: A newer bulking agent in the management of intrinsic urethral sphincter deficiency. J Gynecol Tech 6:51-54, 2000.
66. Amundsen CL, Webster GD: Sacral neuromodulation in an older, urge-incontinent population. Am J Obstet Gynecol 187:1462-1465, 2002.
67. Schurch B, Stohrer M, Kramer G, et al: Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692-697, 2000.
68. Dmochowski RR, Avon M, Ross J, et al: Transvaginal radio frequency treatment of the endopelvic fascia: A prospective evaluation for the treatment of genuine stress urinary incontinence. J Urol 169:1028-1032, 2003.
69. Goldberg RP, Sand PK: Electromagnetic pelvic floor stimulation: Applications for the gynecologist. Obstet Gynecol Surv 55:715-720, 2000.